Has Steven Gordon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $77,770 in general payments to Steven Gordon, MD across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Gordon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Gordon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Gordon, MD

Infectious Disease · Cleveland, OHNPI 1770548737

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $53,850 of the $77,770 with a category attached, or 69.2%. Abbott accounts for 67.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $54,258 and has fallen 99.6% since, to $244 in 2025. Among infectious disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,770in general payments, 2019–2025

Across 83 payments — averaging $936.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$52K
3M Company$16K
Solventum Corporation$5K
Roche Products Limited$4K
Mentor Worldwide LLC$579
Cochlear Americas$125
plus $117 from 3 others

What the payments were for

Consulting fees$53,85069%
Speaking & faculty fees$19,04024%
Travel & lodging$3,4644%
Food & beverage$1,4162%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	55	$52,080
3M Company	4	$15,929
Solventum Corporation	1	$5,040
Roche Products Limited	3	$3,900
Mentor Worldwide LLC	15	$579
Cochlear Americas	2	$125
Advanced Bionics, LLC	1	$54
Angiodynamics, Inc.	1	$40
Visioneering Technologies, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

HeartMate 3 Left Ventricular Dev$30,751
Tegaderm CHG IV Securement Dressing$15,907
HeartMate$9,900
HeartMate 3 Left Ventricular Assist Device$6,300
Curos$5,040
Tegaderm$5,040
AMPLATZER Occluders$3,600
Non-Covered Product$3,420
PICC-CVC Securement Device + Tegaderm CHG IV Securement Dressing$1,907
Tegaderm CHG IV Port Dressing$1,907
Cardiovascular- Research only$1,156
Xofluza$480
MENTOR MemoryGel Resterilizable Gel Sizer$217

How this compares

$77,770 in reported general payments places this provider in the 95th percentile of 308 infectious disease providers in Ohio.

See all infectious disease providers in Ohio →

Medicare billing

Part B allowed, 2024

$46,262

Medicare patients

107

Services billed

547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala	47	$220,721
ZerbaxaCeftolozane/Tazobactam	17	$50,708
DescovyEmtricitabine/Tenofov Alafenam	11	$21,720
JanuviaSitagliptin Phosphate	13	$7,560
Efavirenz	11	$6,014
CeftriaxoneCeftriaxone Sodium	44	$4,742
Vancomycin Hcl	21	$3,309
MicafunginMicafungin Sodium	13	$1,624
Meropenem	14	$1,291
Cefazolin Sodium	18	$507
Penicillin V Potassium	15	$59
Metoprolol Tartrate	13	$8
Pravastatin Sodium	13	$8

Paid to pharmacies, not to this prescriber.

Other infectious disease in Cleveland

Melissa JenkinsCleveland$127K
Grace McComseyCleveland$123K
Alan TaegeCleveland$76K
Benigno RodriguezCleveland$58K
Robin JumpCleveland$52K
Elie SaadeCleveland$32K
David CanadayCleveland$24K
George YendewaCleveland$19K
Kyle BrizendineCleveland$17K
Michael LedermanCleveland$15K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →